日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotection.

先天免疫受体 NLRX1 是 mPTP 开放的新型必需调节因子:对心脏保护的意义

Xiao Y, Hu X, Rudolphi C F, Nollet E E, Nederlof R, Wang Q, Bakker D, Nikolaou Panagiota Efstathia, Knol J C, Haas R R Goeij-de, Henneman A A, Pham T V, Jimenez C R, Grootemaat A E, van der Wel N N, Girardin S E, Kaludercic N, van der Velden J, Onódi Z, Leszek P, Varga Z V, Ferdinandy P, Preckel B, Weber N C, Hollmann M W, Di Lisa F, Zuurbier C J

Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery

骨肉瘤表面蛋白质组学分析鉴定出EPHA2为靶向药物递送的受体

Posthumadeboer, J; Piersma, S R; Pham, T V; van Egmond, P W; Knol, J C; Cleton-Jansen, A M; van Geer, M A; van Beusechem, V W; Kaspers, G J L; van Royen, B J; Jiménez, C R; Helder, M N

The lymnaea cardioexcitatory peptide (LyCEP) receptor: a G-protein-coupled receptor for a novel member of the RFamide neuropeptide family

椎实螺心脏兴奋肽(LyCEP)受体:一种新型RFamide神经肽家族成员的G蛋白偶联受体

Tensen, C P; Cox, K J; Smit, A B; van der Schors, R C; Meyerhof, W; Richter, D; Planta, R J; Hermann, P M; van Minnen, J; Geraerts, W P; Knol, J C; Burke, J F; Vreugdenhil, E; van Heerikhuizen, H